DE60222144D1 - Behandlung von hyperproliferativen zuständen von körperoberflächen - Google Patents
Behandlung von hyperproliferativen zuständen von körperoberflächenInfo
- Publication number
- DE60222144D1 DE60222144D1 DE60222144T DE60222144T DE60222144D1 DE 60222144 D1 DE60222144 D1 DE 60222144D1 DE 60222144 T DE60222144 T DE 60222144T DE 60222144 T DE60222144 T DE 60222144T DE 60222144 D1 DE60222144 D1 DE 60222144D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- body surfaces
- psoriasis
- relates
- hyperproliferative states
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000003463 hyperproliferative effect Effects 0.000 title 1
- 201000004681 Psoriasis Diseases 0.000 abstract 2
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 229940045799 anthracyclines and related substance Drugs 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960000653 valrubicin Drugs 0.000 abstract 1
- ZOCKGBMQLCSHFP-KQRAQHLDSA-N valrubicin Chemical compound O([C@H]1C[C@](CC2=C(O)C=3C(=O)C4=CC=CC(OC)=C4C(=O)C=3C(O)=C21)(O)C(=O)COC(=O)CCCC)[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1 ZOCKGBMQLCSHFP-KQRAQHLDSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Ophthalmology & Optometry (AREA)
- Gynecology & Obstetrics (AREA)
- Otolaryngology (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Farming Of Fish And Shellfish (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK200101218 | 2001-08-14 | ||
| DKPA200101218 | 2001-08-14 | ||
| PCT/DK2002/000530 WO2003015759A2 (en) | 2001-08-14 | 2002-08-12 | Treatment of hyperproliferative conditions of body surfaces |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60222144D1 true DE60222144D1 (de) | 2007-10-11 |
| DE60222144T2 DE60222144T2 (de) | 2008-05-15 |
Family
ID=8160668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60222144T Expired - Lifetime DE60222144T2 (de) | 2001-08-14 | 2002-08-12 | Behandlung von hyperproliferativen zuständen von körperoberflächen |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7345023B2 (de) |
| EP (1) | EP1423126B1 (de) |
| JP (1) | JP4361789B2 (de) |
| AT (1) | ATE371458T1 (de) |
| AU (1) | AU2002320964B2 (de) |
| CY (1) | CY1107814T1 (de) |
| DE (1) | DE60222144T2 (de) |
| DK (1) | DK1423126T3 (de) |
| ES (1) | ES2292789T3 (de) |
| NZ (1) | NZ531408A (de) |
| PT (1) | PT1423126E (de) |
| SI (1) | SI1423126T1 (de) |
| WO (1) | WO2003015759A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2456423A2 (de) | 2009-07-17 | 2012-05-30 | Valderm APS | Behandlung von hyperproliferativen erkrankungen |
| WO2013026453A1 (en) | 2011-08-22 | 2013-02-28 | Valderm Aps | Treatment of inflammatory disorders with anthracyclines |
| ES2934131T3 (es) | 2015-07-10 | 2023-02-17 | Infectopharm Arzneimittel Und Consilium Gmbh | Uso de hidróxido de potasio en el tratamiento de la queratosis actínica |
| CN108098458B (zh) * | 2017-08-09 | 2019-12-24 | 徐先顺 | 一种用于抗hpv6/11的凝胶剂 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149710A (en) * | 1985-04-01 | 1992-09-22 | National Research Development Corporation | Pharmaceutical compositions for treating psoriasis |
| US4739046A (en) * | 1985-08-19 | 1988-04-19 | Luzio Nicholas R Di | Soluble phosphorylated glucan |
| US4946683A (en) * | 1987-11-18 | 1990-08-07 | Vestar, Inc. | Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes |
| WO1989010122A1 (en) * | 1988-04-27 | 1989-11-02 | Yale University | Compositions and methods for treating cutaneous hyperproliferative disorders |
| US6231855B1 (en) * | 1991-03-12 | 2001-05-15 | Istituto Nazionale Per Lo Studio E La Cura Dei Tumori | Monoclonal antibodies as antidotes for anthracycline antibiotics |
| JP3251735B2 (ja) * | 1992-09-25 | 2002-01-28 | 株式会社東芝 | 半導体集積回路装置 |
| US5396195A (en) * | 1993-12-13 | 1995-03-07 | At&T Corp. | Low-power-dissipation CMOS oscillator circuits |
| US6190691B1 (en) * | 1994-04-12 | 2001-02-20 | Adolor Corporation | Methods for treating inflammatory conditions |
| US5900763A (en) * | 1994-10-11 | 1999-05-04 | Motorola, Inc. | Circuit and method of reducing cross-talk in an integrated circuit substrate |
| ES2227536T3 (es) * | 1995-06-27 | 2005-04-01 | Pharmachemie B.V. | Nuevos profarmacos de antraciclina, procedimiento de preparacion asi como su uso en quimioterapia selectiva. |
| DE19720312A1 (de) * | 1997-05-15 | 1998-11-19 | Hoechst Ag | Zubereitung mit erhöhter in vivo Verträglichkeit |
| US5776915A (en) * | 1997-08-12 | 1998-07-07 | Clarion Pharmaceuticals Inc. | Phosphocholines of retinoids |
| DE69932164D1 (de) | 1998-04-28 | 2006-08-10 | Inex Pharmaceuticals Corp | Polyanionische polymere mit verbesserter fusogenfähigkeit |
| US6482802B1 (en) | 1998-05-11 | 2002-11-19 | Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
| WO2000056267A2 (en) * | 1999-03-19 | 2000-09-28 | Waldemar Priebe | Methods and compositions for the manufacture of c-3' and c-4' anthracycline antibiotics |
| JP2001345428A (ja) * | 2000-03-27 | 2001-12-14 | Toshiba Corp | 半導体装置とその製造方法 |
| US6555095B1 (en) * | 2001-12-14 | 2003-04-29 | Avon Products, Inc. | Topical compositions and methods of application |
-
2002
- 2002-08-12 AU AU2002320964A patent/AU2002320964B2/en not_active Ceased
- 2002-08-12 EP EP02754556A patent/EP1423126B1/de not_active Expired - Lifetime
- 2002-08-12 DK DK02754556T patent/DK1423126T3/da active
- 2002-08-12 DE DE60222144T patent/DE60222144T2/de not_active Expired - Lifetime
- 2002-08-12 SI SI200230607T patent/SI1423126T1/sl unknown
- 2002-08-12 JP JP2003520718A patent/JP4361789B2/ja not_active Expired - Fee Related
- 2002-08-12 US US10/486,648 patent/US7345023B2/en not_active Expired - Fee Related
- 2002-08-12 AT AT02754556T patent/ATE371458T1/de active
- 2002-08-12 PT PT02754556T patent/PT1423126E/pt unknown
- 2002-08-12 ES ES02754556T patent/ES2292789T3/es not_active Expired - Lifetime
- 2002-08-12 NZ NZ531408A patent/NZ531408A/en not_active IP Right Cessation
- 2002-08-12 WO PCT/DK2002/000530 patent/WO2003015759A2/en active IP Right Grant
-
2007
- 2007-11-28 CY CY20071101523T patent/CY1107814T1/el unknown
-
2008
- 2008-01-28 US US12/020,852 patent/US8263567B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8263567B2 (en) | 2012-09-11 |
| AU2002320964B2 (en) | 2008-03-13 |
| WO2003015759A2 (en) | 2003-02-27 |
| JP2005504765A (ja) | 2005-02-17 |
| ES2292789T3 (es) | 2008-03-16 |
| NZ531408A (en) | 2005-07-29 |
| US7345023B2 (en) | 2008-03-18 |
| DK1423126T3 (da) | 2008-02-04 |
| DE60222144T2 (de) | 2008-05-15 |
| EP1423126A2 (de) | 2004-06-02 |
| US20040242507A1 (en) | 2004-12-02 |
| PT1423126E (pt) | 2007-12-07 |
| ATE371458T1 (de) | 2007-09-15 |
| EP1423126B1 (de) | 2007-08-29 |
| SI1423126T1 (sl) | 2008-02-29 |
| WO2003015759A3 (en) | 2004-03-04 |
| JP4361789B2 (ja) | 2009-11-11 |
| US20080119546A1 (en) | 2008-05-22 |
| CY1107814T1 (el) | 2013-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106628T1 (el) | Τοπικες φαρμακευτικες συνθεσεις περιλαμβανουσες προανθοκυανιδινες, γλυκυρροχητινικο οξυ και τελμεστεϊνη για τη θεραπεια των δερματιτιδων | |
| BG66080B1 (bg) | Заместени тиоацетамиди | |
| WO2003055878A8 (de) | 2-heteroarylcarbonsäureamide | |
| EA200100524A1 (ru) | Амиды антраниловой кислоты и их применение в качестве лекарственных средств | |
| ATE290401T1 (de) | Topisch anwendbare mittel gegen nagelpilzerkrankungen | |
| NO20024005D0 (no) | Pteridinforbindelser for behandling av psoriasis | |
| DE60228761D1 (de) | Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung | |
| IS6194A (is) | Serínprótínasar úr fiski og notkun þeirra í lyf og snyrtivörur | |
| ATE339187T1 (de) | Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt | |
| WO2003018619A3 (en) | Antimicrobial and anti-inflammatory peptides | |
| BRPI0407662A (pt) | derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas | |
| ATE406371T1 (de) | Wirkstoffe für die verminderung von amyloid precursor protein und die behandlung von schwachsinn, und deren verfahren der verwendung | |
| ATE256392T1 (de) | Verwendung von polyaminosäurederivate als konservierungsmittel | |
| ATE160561T1 (de) | L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen | |
| BR0209541A (pt) | Uso das imidazotriazinonas 2-fenil-substituìdas | |
| BRPI0211635B8 (pt) | composto ciclo-hexil-sulfona, uso do mesmo, e, composição farmacêutica | |
| CY1107814T1 (el) | Θεραπεια παθησεων υπερπολλαπλασιασμου των επιφανειων του σωματος | |
| MX9403032A (es) | Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos. | |
| UY26930A1 (es) | Amidas de ácido fenilciclohexanocarboxílico sustituido y su uso | |
| TR200003451T2 (tr) | Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları | |
| ATE241640T1 (de) | Fusidinsäure-derivate | |
| DOP2002000472A (es) | Amidas de acido piperazinciclohexanocarboxilico sustituidas y su utilizacion. | |
| WO2002070537A3 (en) | Fusidic acid derivatives | |
| CY1111319T1 (el) | Ενωση 4-μεθυλεξανοϊκης κααλαλιδης f | |
| DOP2001000245A (es) | Amidas de acido fenilciclohexanocarboxilico sustituido y su uso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |